摘要：
(正)1文献来源Chen J,Lu L,Wen T,et al. 2021 ESMO 945P-Adjuvant lenvatinib in combination with TACE for hepatocellular carcinoma patients with high risk of postoperative relapse （LANCE）:Updated results from a multi-center prospective cohort study[J]. Ann Oncol,2021,32（5S）:S818-S828.
